ES2177063T3 - Derivados de la 3-oxo-2(h)-1,2,4-triazina como ligandos de los receptores 5ht1a. - Google Patents

Derivados de la 3-oxo-2(h)-1,2,4-triazina como ligandos de los receptores 5ht1a.

Info

Publication number
ES2177063T3
ES2177063T3 ES98949061T ES98949061T ES2177063T3 ES 2177063 T3 ES2177063 T3 ES 2177063T3 ES 98949061 T ES98949061 T ES 98949061T ES 98949061 T ES98949061 T ES 98949061T ES 2177063 T3 ES2177063 T3 ES 2177063T3
Authority
ES
Spain
Prior art keywords
alkyl
optionally substituted
group
hydrogen
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98949061T
Other languages
English (en)
Inventor
Jean-Francois Patoiseau
Elisabeth Dupont-Passelaigue
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2177063T3 publication Critical patent/ES2177063T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

Derivados de la 3-oxo-(2H)-1,2,4-triazina que corresponden a la fórmula general I en la cual - R1 representa : hidrógeno, únicamente cuando A es un átomo de nitrógeno eventualmente sustituido. un grupo alcoilo con C1-C4 lineal o ramificado un grupo alcoilo con C1-C4, estando el núcleo fenilo eventualmente sustituido por uno o varios grupos alcoilo con C1-C4, alcoxi con C1-C3, halógeno , trifluorometilo. - R2 representa : hidrógeno un radical alcoilo con C1-C4 lineal o ramificado un grupo fenilo o fenilalcoilo con C1-C4, estando el núcleo fenilo eventualmente sustituido por uno o varios grupos alcoilo con C1-C4, alcoxi con C1-C3, halógeno, trifluorometilo. - A representa un átomo de oxígeno o un átomo de nitrógeno eventualmente sustituido por NR3. - R3 representa el hidrógeno o un grupo metilo. - B representa un grupo del tipo en el cual Ar representa a su vez una estructura aromática fenilo, piridilo o pirimidilo, eventualmente sustituida poruno o varios grupos alcoilo con C1-C3, alcoxi con C1-C3, hidroxi, trifluorometilo o halógeno y n puede tomar los valores enteros de 3 al 5. en el cual Ar es tal como se ha definido en la fórmula
ES98949061T 1997-10-16 1998-10-14 Derivados de la 3-oxo-2(h)-1,2,4-triazina como ligandos de los receptores 5ht1a. Expired - Lifetime ES2177063T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712955A FR2769912B1 (fr) 1997-10-16 1997-10-16 Nouveaux derives de la 3-oxo- (2h)-1,2,4 triazine leur preparation et leur application en therapeutique humaine

Publications (1)

Publication Number Publication Date
ES2177063T3 true ES2177063T3 (es) 2002-12-01

Family

ID=9512298

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98949061T Expired - Lifetime ES2177063T3 (es) 1997-10-16 1998-10-14 Derivados de la 3-oxo-2(h)-1,2,4-triazina como ligandos de los receptores 5ht1a.

Country Status (14)

Country Link
US (1) US6303603B1 (es)
EP (1) EP1023287B1 (es)
JP (1) JP4413424B2 (es)
CN (1) CN1128147C (es)
AT (1) ATE219076T1 (es)
AU (1) AU761653B2 (es)
BR (1) BR9812928B1 (es)
CA (1) CA2306428C (es)
DE (1) DE69806036T2 (es)
DK (1) DK1023287T3 (es)
ES (1) ES2177063T3 (es)
FR (1) FR2769912B1 (es)
PT (1) PT1023287E (es)
WO (1) WO1999020622A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001267421A1 (en) * 2000-05-12 2001-11-20 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
AU2003300031A1 (en) * 2002-10-11 2004-05-04 Cytokinetics, Inc. Compounds, compositions, and methods
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
WO2006089053A2 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
DE4442229A1 (de) * 1994-11-28 1996-05-30 Hoechst Schering Agrevo Gmbh Alkylidenhydrazinophenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren
FR2727682A1 (fr) * 1994-12-02 1996-06-07 Pf Medicament Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament

Also Published As

Publication number Publication date
BR9812928B1 (pt) 2013-03-19
AU761653B2 (en) 2003-06-05
DK1023287T3 (da) 2002-10-14
AU9545798A (en) 1999-05-10
WO1999020622A1 (fr) 1999-04-29
PT1023287E (pt) 2002-11-29
JP4413424B2 (ja) 2010-02-10
DE69806036D1 (de) 2002-07-18
EP1023287B1 (fr) 2002-06-12
CA2306428A1 (fr) 1999-04-29
US6303603B1 (en) 2001-10-16
FR2769912B1 (fr) 2000-03-10
CN1278815A (zh) 2001-01-03
JP2001520226A (ja) 2001-10-30
CN1128147C (zh) 2003-11-19
EP1023287A1 (fr) 2000-08-02
ATE219076T1 (de) 2002-06-15
BR9812928A (pt) 2000-08-08
CA2306428C (fr) 2010-01-12
FR2769912A1 (fr) 1999-04-23
DE69806036T2 (de) 2003-01-30

Similar Documents

Publication Publication Date Title
CO4970780A1 (es) Nuevos compuestos heterociclicos de piridazina
YU1900A (sh) Derivati ariloksiarilsulfonilamino hidroksaminske kiseline
HUP0202799A2 (hu) Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény
DK1022272T3 (da) Substituerede, fusionerede, heterocykliske forbindelser
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
DE69332792D1 (de) 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide
DK0733621T3 (da) Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
MY140749A (en) Novel piperidine compound
MXPA04002569A (es) H6,7-dihidro-5h-pirazolo[1,2-a]pirazol-1-onas espirociclicas que controlan citocinas inflamatorias.
DK0947504T3 (da) 16-en-vitamin D-derivater
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
ES2177063T3 (es) Derivados de la 3-oxo-2(h)-1,2,4-triazina como ligandos de los receptores 5ht1a.
DK0841327T3 (da) Triazolantisvampemiddel
WO2000024717A3 (en) Isoquinoline derivatives
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
NO955328L (no) Pyridazinon-derivater
BG104309A (en) 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
TW350843B (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
DK193090A (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
TW351717B (en) Pyenyl-substituted cyclic ketoenols
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel